NCT06566092
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06566092
Title Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Iovance Biotherapeutics, Inc.
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Children's Hospital of Colorado Aurora Colorado 80045 United States Details
Johns Hopkins All Children's Hospital St. Petersburg Florida 33701 United States Details
Rutgers Cancer Institute New Brunswick New Jersey 08901 United States Details
Roswell Park Cancer Institute Buffalo New York 14203 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field